-
24P Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
B.V. Sinn, M. Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, Katharina Sychra, +12 more
0citations -
187P Routine care of early breast cancer (stage I-III) in Germany: Data of the prospective, intersectoral research platform OPAL2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
A. Welt, M-O. Zahn, A. Wöckel, E. Stickeler, M. Thoma, Arnd Nusch, +11 more
0citations -
266P Association of RAD51 and efficacy outcomes in patients with HER2-negative breast cancer (BC) and homologous recombination deficiency (HRD): Post-hoc analysis of the GeparOla trial
Guillermo Javierre Villacampa, Natalie Filmann, P.A. Fasching, J. Balmaña, Thomas Karn, Federik Marme, +12 more
0citations -
1485P Atezolizumab plus bevacizumab before or after transarterial chemoembolization in hepatocellular carcinoma: Interim analysis of the DEMAND (AIO-HEP-0418) randomized phase II clinical trial2025 Annals of Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Alexander B. Philipp, Najib Ben Khaled, Jens Ricke, Julia V. Mayerle, Dirk Waldschmidt, Ilja Kubisch, +12 more
0citations -
1192P Characterization of patients with newly diagnosed advanced ovarian cancer not receiving maintenance therapy: Results of a prospective real-world study (NOGGO ov54, SCOUT-1)
Pauline Wimberger, Elena Ioana Braicu, Klaus Pietzner, J. Goldmann, Karol Kubiak, Cosima V. M. Brucker, +14 more
0citations -
SO-16 The tumour-stroma ratio as an additional parameter to the TNM classification: The UNITED study2020 Annals of Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Wilma E. Mesker, Marloes A. Smit, Gabi W. van Pelt, Hans A. J. Gelderblom, J. Han van Krieken, R.A.E.M. Tollenaar
0citations -
763P The influence of multidisciplinary team meetings on treatment decisions in muscle invasive bladder cancer: A nationwide study in the Netherlands
Janneke E. W. Walraven, Theodora M. Ripping, Jorg Reinier Oddens, Bas W.G. van Rhijn, Catharina A. Goossens‐Laan, Maarten C.C.M. Hulshof, +8 more
0citations -
1103P Long-term survival of real-world advanced melanoma patients treated with targeted therapy2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Rawa Kamaran Ismail, Anthonius de Boer, Maaike van Dartel, Doranne L. Hilarius, Michiel C.T. van Zeijl, F. Van Den Eertwegh, +14 more
0citations -
1626MO Treatment expectations and preferences for quality versus quantity of life in patients with advanced soft tissue sarcomas starting palliative 1st line chemotherapy
Eugenie Younger, Robin L. Jones, Dide den Hollander, Vicky L. M. N. Soomers, Ingrid M.E. Desar, Astrid W. Oosten, +5 more
0citations -
LBA73 The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:012020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches Open access
Pia Kvistborg, Anastasia Gangaev, Steven L. C. Ketelaars, S. Patiweal, Anna Dopler, Olga I. Isaeva, +13 more
0citations -
861P Limited implementation of the ESMO-ESGO (European Society of Gynaecological Oncology)-ESTRO (European Society for Radiotherapy and Oncology) consensus conference recommendations (CCR) on endometrial cancer (EC)
Cristiana Sessa, Nicoletta Colombo, Carien L. Creutzberg, Nicole Concin, Pauline Wimberger, K.A. Marinoni, +3 more
0citations -
731P The impact of proton pump inhibitors on pazopanib exposure2020 Annals of Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Stefanie D. Krens, Floor J.E. Lubberman, Frank G. A. Jansman, David Marinus Burger, Paul Hamberg, Walter L. Vervenne, +4 more
0citations